## BG: Bunge Limited - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -3.4% below STRENGTH zone (4.0-10.0%); PEG 1.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($88.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | B of A Securiti | $112 | $95 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | B of A Securiti | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 66.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Glencore Plc: 17.0% (+100.0%)
- Canada Pension Plan : 13.6% (+999418.6%)
- Vanguard Group Inc: 8.7% (+0.8%)
- Capital World Invest: 8.4% (+4.5%)
- Blackrock Inc.: 8.2% (-1.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.71 elevated, pricing in significant growth expectations. Forward P/E 10.5x attractive for 19% earnings growth. Revenue growth strong at 36% YoY. Analyst sentiment positive (1 raises, avg +18%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.7B |
| Beta | 0.78 |
| 52W Range | $67.40 - $99.55 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.71 |
| Forward P/E | 10.5 |
| Current P/E | 12.5 |
| YoY Growth | 19.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -3.4% (minimal 5-day change). Below STRENGTH zone by 7.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.0%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-0.58), momentum weakening. RSI neutral at 48.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.36% (CS: 20) | Weak |
| RSI_14 | 48.2 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 1.135x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $93.27
- **Stop Loss:** $88.55 (5.1% risk)
- **Target:** $97.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 292
- **Position Value:** $27,234.84
- **Portfolio %:** 27.23%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $1.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.97 | $2.27 | +15.3% |
| 2025Q2 | $1.08 | $1.31 | +20.9% |
| 2025Q1 | $1.31 | $1.81 | +38.3% |
| 2024Q4 | $2.25 | $2.13 | -5.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*